|
Market Closed -
NYSE
04:00:00 09/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.650 USD | -0.75% |
|
+2.32% | +47.22% |
| 08-12 | Protalix BioTherapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 | |
| 08-12 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 214M 184M 173M 158M 294M 20.24B 296M 2.05B 792M 10.35B 802M 784M 32.92B | P/E 2026 * |
13.9x | P/E 2027 * | 48.2x |
|---|---|---|---|---|---|
| Enterprise Value | 214M 184M 173M 158M 294M 20.24B 296M 2.05B 792M 10.35B 802M 784M 32.92B | EV / Sales 2026 * |
2.68x | EV / Sales 2027 * | 3.13x |
| Free-Float |
96.12% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| PLX | Delayed | |
CBOE
| PLX | Real-time | |
|
Tradegate
| PBDA | Real-time | |
|
Börse Stuttgart
| PBDA | Delayed | |
|
Deutsche Boerse AG
| PBDA | Delayed | |
|
Boerse Muenchen
| PBDA | Real-time |
Last Transcript : Protalix BioTherapeutics, Inc.
| 1 day | -0.75% | ||
| 1 week | +2.32% | ||
| Current month | +3.11% | ||
| 1 month | +7.72% | ||
| 3 months | +35.20% | ||
| 6 months | +1.15% | ||
| Current year | +47.22% |
| 1 week | 2.57 |  | 2.68 |
| 1 month | 2.17 | | 2.7 |
| Current year | 1.72 | | 3.19 |
| 1 year | 1.6 | | 3.19 |
| 3 years | 0.82 | | 3.19 |
| 5 years | 0.7 | | 3.55 |
| 10 years | 0.7 | | 15.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dror Bashan
CEO | Chief Executive Officer | 59 | 30/06/2019 |
Gilad Mamlok
DFI | Director of Finance/CFO | 57 | 24/08/2025 |
Ori Kalid
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amos Bar Shalev
BRD | Director/Board Member | 73 | 01/07/2008 |
Aharon Schwartz
BRD | Director/Board Member | 83 | 01/11/2014 |
Dror Bashan
BRD | Director/Board Member | 59 | 30/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/9/26 | Free | Chairman | 25,500 | 0.0316% | ||
| 3/9/26 | Free | Chief Executive Officer | 480,000 | 0.5957% | ||
| 3/9/26 | Free | Director | 25,500 | 0.0316% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.75% | +2.32% | +67.72% | +48.88% | 214M | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,002B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 649B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 440B | |
| -0.49% | -0.09% | +29.37% | +37.42% | 346B | |
| -1.02% | -15.58% | +8.62% | +25.54% | 263B | |
| -0.39% | -0.84% | -0.84% | +13.08% | 250B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 213B | |
| -1.16% | -4.36% | -14.82% | -57.82% | 201B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 182B | |
| Average | -2.08% | -1.62% | +27.87% | +43.78% | 354.39B | |
| Weighted average by Cap. | -1.41% | -2.39% | +32.79% | +57.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 79.8M 68.61M 64.55M 58.9M 110M 7.56B 110M 765M 296M 3.87B 300M 293M 12.3B | 68.19M 58.63M 55.16M 50.34M 93.94M 6.47B 94.43M 654M 253M 3.3B 256M 250M 10.52B |
| Net income | 15.38M 13.22M 12.44M 11.35M 21.18M 1.46B 21.29M 147M 57.01M 745M 57.73M 56.47M 2.37B | 4.46M 3.84M 3.61M 3.29M 6.15M 423M 6.18M 42.77M 16.55M 216M 16.76M 16.39M 688M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | US$2.650 | -0.75% | 908,363 |
| 04/09/26 | US$2.670 | +1.91% | 863,718 |
| 03/09/26 | US$2.620 | +1.16% | 942,012 |
| 02/09/26 | US$2.590 | 0.00% | 454,863 |
| 01/09/26 | US$2.590 | +0.78% | 598,262 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PLX Stock
Select your edition
All financial news and data tailored to specific country editions
